These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31692558)

  • 1. Effect of narrowband ultraviolet B therapy on serum levels of CD26/dipeptidyl-peptidase IV and truncated forms of substance P in psoriasis patients with pruritus.
    Kongthong S; Phumyen A; Meephansan J
    Clin Cosmet Investig Dermatol; 2019; 12():597-604. PubMed ID: 31692558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus.
    Komiya E; Hatano R; Otsuka H; Itoh T; Yamazaki H; Yamada T; Dang NH; Tominaga M; Suga Y; Kimura U; Takamori K; Morimoto C; Ohnuma K
    J Dermatol Sci; 2017 Jun; 86(3):212-221. PubMed ID: 28365081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral endomorphins drive mechanical alloknesis under the enzymatic control of CD26/DPPIV.
    Komiya E; Tominaga M; Hatano R; Kamikubo Y; Toyama S; Sakairi H; Honda K; Itoh T; Kamata Y; Tsurumachi M; Kishi R; Ohnuma K; Sakurai T; Morimoto C; Takamori K
    J Allergy Clin Immunol; 2022 Mar; 149(3):1085-1096. PubMed ID: 34411589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of narrowband ultraviolet B phototherapy and levels of serum vitamin D3 in psoriasis: A prospective study.
    Gupta A; Arora TC; Jindal A; Bhadoria AS
    Indian Dermatol Online J; 2016; 7(2):87-92. PubMed ID: 27057487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.
    Yıldırım FE; Karaduman A; Pinar A; Aksoy Y
    Int J Dermatol; 2011 Aug; 50(8):948-55. PubMed ID: 21781066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected female sex workers.
    Songok EM; Osero B; McKinnon L; Rono MK; Apidi W; Matey EJ; Meyers AF; Luo M; Kimani J; Wachihi C; Ball BT; Plummer FA; Mpoke S
    Virol J; 2010 Nov; 7():343. PubMed ID: 21108831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-O-methyltransferase activity is higher in psoriasis patients and is down-regulated by narrowband ultraviolet B treatment.
    Magina S; Moura E; Serrão MP; Moura D; Vieira-Coelho MA
    Eur J Dermatol; 2013; 23(1):49-52. PubMed ID: 23399536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque-type psoriasis--a randomized single-blinded placebo-controlled study.
    Mahajan R; Kaur I; Kanwar AJ
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):595-600. PubMed ID: 20015056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
    Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
    Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naïve rheumatoid arthritis.
    Grujic M; Matic IZ; Crnogorac MD; Velickovic AD; Kolundzija B; Cordero OJ; Juranic Z; Prodanovic S; Zlatanovic M; Babic D; Damjanov N
    Clin Chem Lab Med; 2017 Jan; 55(1):73-81. PubMed ID: 27341562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients.
    Narbutt J; Olejniczak I; Sobolewska-Sztychny D; Sysa-Jedrzejowska A; Słowik-Kwiatkowska I; Hawro T; Lesiak A
    Arch Dermatol Res; 2013 Apr; 305(3):191-5. PubMed ID: 23108364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of narrowband ultraviolet B treatment on psoriasis severity and serum levels of angiopoietin-2: A cross-sectional controlled study.
    Nada HA; Elshabrawy MM; Elenain SAA; Elsaie ML
    J Cosmet Dermatol; 2022 Jan; 21(1):392-395. PubMed ID: 34496134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.
    Kobayashi H; Hosono O; Mimori T; Kawasaki H; Dang NH; Tanaka H; Morimoto C
    J Rheumatol; 2002 Sep; 29(9):1858-66. PubMed ID: 12233879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrowband ultraviolet B phototherapy does not influence serum and red cell folate levels in patients with psoriasis.
    Rose RF; Batchelor RJ; Turner D; Goulden V
    J Am Acad Dermatol; 2009 Aug; 61(2):259-62. PubMed ID: 19493587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical effects of psoriasis treatment regimens among calcipotriol alone, narrowband ultraviolet B phototherapy alone, combination of calcipotriol and narrowband ultraviolet B phototherapy once a week, and combination of calcipotriol and narrowband ultraviolet B phototherapy more than twice a week.
    Takahashi H; Tsuji H; Ishida-Yamamoto A; Iizuka H
    J Dermatol; 2013 Jun; 40(6):424-7. PubMed ID: 23414298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
    Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
    Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial.
    Lynch M; Ahern TB; Timoney I; Sweeney C; Kelly G; Hughes R; Tobin AM; O'Shea D; Kirby B
    Trials; 2016 Jan; 17():29. PubMed ID: 26767505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the dipeptidyl peptidase IV (DPPIV/CD26) based prodrug approach to different amine-containing drugs.
    Diez-Torrubia A; García-Aparicio C; Cabrera S; De Meester I; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2010 Jan; 53(2):559-72. PubMed ID: 20000418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas.
    Carbone A; Cozzi M; Gloghini A; Pinto A
    Hum Pathol; 1994 Dec; 25(12):1360-5. PubMed ID: 8001932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells.
    Christopherson KW; Hangoc G; Broxmeyer HE
    J Immunol; 2002 Dec; 169(12):7000-8. PubMed ID: 12471135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.